Article
Yan Ji, Jin Y. Jin, David M. Hyman, Geoffrey Kim and Ajit Suri
Building Winning Oncology Teams That Last
Clips
Summary
In this episode of the Oncology Voice Network, Dr. Kirk Shepard sits down with Spencer Weneck and Christian Camp to break down what truly makes an oncology organization resilient, competitive, and future-ready.
How do leading pharma and biotech teams keep up with oncology’s relentless pace? In this episode of the Oncology Voice Network, Dr. Kirk Shepard sits down with Spencer Weneck and Christian Camp to break down what truly makes an oncology organization resilient, competitive, and future-ready. Hear firsthand insights into today’s most urgent challenges: navigating the shift from an employer to a candidate-driven market, adapting to patent cliffs and M&A waves, and outsmarting the industry’s unparalleled war for talent. Discover why talent development, cultural fit, and cross-functional leadership are make-or-break factors—and why so many companies lose their way by ignoring them. Get inspired by real-life examples, honest lessons from failure, and a deep dive into how shared learning environments like OVN are resetting industry standards. Listen now and future-proof your oncology team.
Related Topics
You May Also Like
Yan Ji, Jin Y. Jin, David M. Hyman, Geoffrey Kim and Ajit Suri
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Charles L. Bennett , Sumimasa Nagai , Andrew C. Bennett , Shamia Hoque , Chadi Nabhan , Martin W. Schoen , William J. Hrushesky , Stefano Luminari , Paul Ray , Paul R. Yarnold , Bart Witherspoon , Josh Riente , Laura Bobolts , John Brusk , Rebecca Tombles
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions
Podcast
MSL Talk: Tom Caravela, Josh Corriveau
MSL Career Options: The transition from Field Medical to Medical Director
Article
R. Kurzrock, L.A. Gurski, R.W. Carlson, D.S. Ettinger, S.M. Horwitz, S.K. Kumar, L. Million, M. von Mehren, A.B. Benson III
Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
Article
Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr